SEC Form 4/A · accession 0001179110-15-012424
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Robert B Ford
Officer — Executive Vice President
Period of report
Jun 1, 2015
Accepted (ET)
Aug 20, 2015 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1,F2 | $48.90 | Jun 1, 2015 | A | 14,243 | A | Jun 1, 2016 | May 31, 2025 | Common shares | 14,243 | 14,243 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 4,748 on 6/1/2016, 4,747 on 6/1/2017, and 4,748 on 6/1/2018.
- F2This Form 4/A amends the number of derivative securities acquired on June 1, 2015.